Literature DB >> 19270527

Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives.

G-One Ahn1, J Martin Brown.   

Abstract

In this review, we highlight some of recent studies underscoring the importance of the tumor microenvironment, especially the role of bone marrow-derived myeloid cells, in restoring tumor growth after irradiation. Myeloid cells are hematopoietic cells that give rise to monocytes and macrophages in the peripheral blood and tissues. These cells have been shown to be proangiogenic in tumors promoting tumor growth. We also discuss our previously unpublished results on the effect of irradiation on the tumor vasculature including pericyte and basement membrane coverage to the endothelium of tumor blood vessels. We summarize the clinical significance of these studies including the use of MMP-9 inhibitors, administering white blood cell boosters, or planning safety margin of tumor volumes, in order to improve overall clinical benefits in cancer patients treated with radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270527      PMCID: PMC2862685          DOI: 10.4161/cc.8.7.8075

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  69 in total

1.  Universal GFP reporter for the study of vascular development.

Authors:  T Motoike; S Loughna; E Perens; B L Roman; W Liao; T C Chau; C D Richardson; T Kawate; J Kuno; B M Weinstein; D Y Stainier; T N Sato
Journal:  Genesis       Date:  2000-10       Impact factor: 2.487

2.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Authors:  D Lyden; K Hattori; S Dias; C Costa; P Blaikie; L Butros; A Chadburn; B Heissig; W Marks; L Witte; Y Wu; D Hicklin; Z Zhu; N R Hackett; R G Crystal; M A Moore; K A Hajjar; K Manova; R Benezra; S Rafii
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

3.  Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Authors:  Alexandre Kaliski; Laurence Maggiorella; Keith A Cengel; Denis Mathe; Valerie Rouffiac; Paule Opolon; Nathalie Lassau; Jean Bourhis; Eric Deutsch
Journal:  Mol Cancer Ther       Date:  2005-11       Impact factor: 6.261

4.  Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

Authors:  Prakash Chinnaiyan; Shyhmin Huang; Geetha Vallabhaneni; Eric Armstrong; Sooryanarayana Varambally; Scott A Tomlins; Arul M Chinnaiyan; Paul M Harari
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.

Authors:  Daniel Zips; Wolfgang Eicheler; Peter Geyer; Franziska Hessel; Annegret Dörfler; Howard D Thames; Martin Haberey; Michael Baumann
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

6.  DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.

Authors:  Eric T Shinohara; Ling Geng; Jiahui Tan; Heidi Chen; Yu Shir; Eric Edwards; James Halbrook; Edward A Kesicki; Adam Kashishian; Dennis E Hallahan
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways.

Authors:  M Zeng; L Narayanan; X S Xu; T A Prolla; R M Liskay; P M Glazer
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

Review 8.  Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

Authors:  Massimo Di Maio; Cesare Gridelli; Ciro Gallo; Frances Shepherd; Franco Vito Piantedosi; Silvio Cigolari; Luigi Manzione; Alfonso Illiano; Santi Barbera; Sergio Federico Robbiati; Luciano Frontini; Elena Piazza; Giovanni Pietro Ianniello; Enzo Veltri; Federico Castiglione; Francesco Rosetti; Vittorio Gebbia; Lesley Seymour; Paolo Chiodini; Francesco Perrone
Journal:  Lancet Oncol       Date:  2005-09       Impact factor: 41.316

9.  MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Authors:  L M Coussens; C L Tinkle; D Hanahan; Z Werb
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

10.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Authors:  Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Ronald G Crystal; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

View more
  17 in total

1.  Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.

Authors:  Sabina Sangaletti; Claudio Tripodo; Chiara Ratti; Silvia Piconese; Rossana Porcasi; Rosalba Salcedo; Giorgio Trinchieri; Mario P Colombo; Claudia Chiodoni
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy.

Authors:  M Giuliani; L R Sampson; O Wong; J Gay; L W Le; B C J Cho; A Brade; A Sun; A Bezjak; A J Hope
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

Review 3.  Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes.

Authors:  Juan R Cubillos-Ruiz; Melanie Rutkowski; Jose R Conejo-Garcia
Journal:  Cell Cycle       Date:  2010-01-26       Impact factor: 4.534

Review 4.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

5.  Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.

Authors:  Serk In Park; Changki Lee; W David Sadler; Amy J Koh; Jacqueline Jones; Jung Won Seo; Fabiana N Soki; Sun Wook Cho; Stephanie D Daignault; Laurie K McCauley
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

Review 6.  Strategies to improve radiotherapy with targeted drugs.

Authors:  Adrian C Begg; Fiona A Stewart; Conchita Vens
Journal:  Nat Rev Cancer       Date:  2011-04       Impact factor: 60.716

Review 7.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

Review 8.  Strategies for optimizing the response of cancer and normal tissues to radiation.

Authors:  Everett J Moding; Michael B Kastan; David G Kirsch
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

9.  Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.

Authors:  Serk In Park; Jinhui Liao; Janice E Berry; Xin Li; Amy J Koh; Megan E Michalski; Matthew R Eber; Fabiana N Soki; David Sadler; Sudha Sud; Sandra Tisdelle; Stephanie D Daignault; Jeffrey A Nemeth; Linda A Snyder; Thomas J Wronski; Kenneth J Pienta; Laurie K McCauley
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

Review 10.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.

Authors:  Holly E Barker; James T E Paget; Aadil A Khan; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.